Literature DB >> 9328020

Prefrontal cortical and hippocampal modulation of dopamine-mediated effects.

B K Lipska1, D R Weinberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9328020     DOI: 10.1016/s1054-3589(08)60869-8

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


× No keyword cloud information.
  6 in total

1.  Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.

Authors:  Kuei-Yuan Tseng; Barbara L Lewis; Barbara K Lipska; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2007-01-03       Impact factor: 13.382

2.  Altered prefrontal cortical metabolic response to mesocortical activation in adult animals with a neonatal ventral hippocampal lesion.

Authors:  Kuei Y Tseng; Fatema Amin; Barbara L Lewis; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2006-06-14       Impact factor: 13.382

3.  Emergence of stereotypies in juvenile monkeys (Macaca mulatta) with neonatal amygdala or hippocampus lesions.

Authors:  M D Bauman; J E Toscano; B A Babineau; W A Mason; D G Amaral
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

Review 4.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

5.  COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.

Authors:  Abhay A Shukla; Manish Jha; Thomas Birchfield; Shibani Mukherjee; Kelly Gleason; Salim Abdisalaam; Aroumougame Asaithamby; Beverley Adams-Huet; Carol A Tamminga; Subroto Ghose
Journal:  Schizophr Res       Date:  2016-03-24       Impact factor: 4.939

6.  Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.

Authors:  Mayada Akil; Bhaskar S Kolachana; Debora A Rothmond; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.